Epicardial ganglionated plexus ablation: Safety considerations beyond the atria
- PMID: 31389095
- PMCID: PMC6786910
- DOI: 10.1111/jce.14095
Epicardial ganglionated plexus ablation: Safety considerations beyond the atria
Conflict of interest statement
Comment on
-
Epicardial ganglionated plexi ablation increases the inducibility of ventricular tachyarrhythmias in a canine postmyocardial infarction model.J Cardiovasc Electrophysiol. 2019 May;30(5):741-746. doi: 10.1111/jce.13912. Epub 2019 Apr 7. J Cardiovasc Electrophysiol. 2019. PMID: 30957344
References
-
- Wu B, Xu S, Dai R, Hong M, Wu H, Lin R. Epicardial ganglionated plexi ablation increases the inducibility of ventricular tachyarrhythmias in a canine postmyocardial infarction model. Journal of cardiovascular electrophysiology 2019;30:741–746. - PubMed
-
- He B, Lu Z, He W et al. Effects of ganglionated plexi ablation on ventricular electrophysiological properties in normal hearts and after acute myocardial ischemia. Int J Cardiol 2013;168:86–93. - PubMed
-
- Waldron NH, Cooter M, Haney JC et al. Temporary autonomic modulation with botulinum toxin type A to reduce atrial fibrillation after cardiac surgery. Heart Rhythm 2019;16:178–184. - PubMed
-
- Pokushalov E, Kozlov B, Romanov A et al. Long-Term Suppression of Atrial Fibrillation by Botulinum Toxin Injection Into Epicardial Fat Pads in Patients Undergoing Cardiac Surgery: One-Year Follow-Up of a Randomized Pilot Study. Circ Arrhythm Electrophysiol 2015;8:1334–41. - PubMed
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
